Staphyt secures capital investment from Unigrains, Bpifrance, Nord Est Partenaires, and IRD Invest to accelerate its growth and international expansion in the agronomy sector.
Overview of the Target
Staphyt, a leading global agronomy research company based in Inchy-en-Artois, Hauts-de-France, has opened its capital to several investors including Unigrains, Bpifrance, Nord Est Partenaires, and IRD Invest. Founded in 1989, Staphyt provides various services such as field trials, laboratory analyses, and regulatory consulting to international clients in the agrochemical, biosolutions, and seed sectors. The company operates over 50 testing sites in 17 countries across three continents, offering a comprehensive service portfolio for nutrition and crop protection product stakeholders, ranging from major corporations to innovative SMEs.
With a successful track record of growth through acquisitions—having completed 16 purchases since its inception—Staphyt continues to expand its global footprint, including four acquisitions in Brazil during its entry into that market between 2021 and 2022. Under the leadership of President Arthur Boisleux and General Manager Olivier Marchioro, the family-owned group employs nearly 600 staff and reported a revenue exceeding €45 million.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The French agronomy sector stands as one of the most vital components of the global agricultural framework. Renowned for its significant contribution to food production and sustainable agricultural practices, France boasts a rich arra
Similar Deals
INEOS → TotalEnergies' 50% share of Naphtachimie, Appryl, Gexaro, and 3TC
2024
Unigrains, Bpifrance, Nord Est Partenaires, IRD Invest
invested in
Staphyt
in 2025
in a Other Private Equity deal
Disclosed details
Revenue: $48M